US Stock MarketDetailed Quotes

VNDA Vanda Pharmaceuticals

Watchlist

6.110
+0.040+0.66%

Close Jul 19 16:00 ET

6.000
-0.110-1.80%

Pre 08:00 ET

355.59MMarket Cap-67888P/E (TTM)

Vanda Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

-24.06%47.46M

-24.27%192.64M

-29.79%45.27M

-40.58%38.82M

-28.47%46.06M

3.83%62.5M

-5.32%254.38M

-5.20%64.48M

-6.82%65.32M

-5.17%64.39M

Operating revenue

-24.06%47.46M

-24.27%192.64M

-29.79%45.27M

-40.58%38.82M

-28.47%46.06M

3.83%62.5M

-5.32%254.38M

-5.20%64.48M

-6.82%65.32M

-5.17%64.39M

Cost of revenue

-27.94%3.44M

-39.07%14.8M

-44.53%3.46M

-51.53%3.06M

-42.25%3.5M

-15.73%4.77M

-5.26%24.28M

0.03%6.24M

-7.02%6.32M

-7.72%6.06M

Gross profit

-23.74%44.02M

-22.71%177.84M

-28.21%41.81M

-39.40%35.75M

-27.04%42.56M

5.86%57.72M

-5.33%230.1M

-5.73%58.24M

-6.79%59M

-4.89%58.33M

Operating expense

-4.42%53.26M

-14.29%191.8M

-5.25%48.91M

-24.22%41.75M

-17.22%45.42M

-10.41%55.72M

11.39%223.77M

-2.88%51.62M

4.98%55.09M

12.06%54.87M

Selling and administrative expenses

-16.67%30.09M

-17.29%112.88M

-27.97%23.61M

-17.04%24.77M

-13.95%28.4M

-11.61%36.1M

10.03%136.49M

-1.99%32.78M

-8.02%29.85M

16.42%33M

Research and development costs

9.97%21.15M

-10.43%76.82M

31.89%24.34M

-33.22%16.6M

-22.54%16.65M

-8.26%19.24M

13.81%85.77M

-4.54%18.45M

26.48%24.86M

6.13%21.49M

Depreciation amortization depletion

432.45%2.02M

37.86%2.09M

151.45%953K

0.26%380K

-0.26%378K

0.00%379K

2.57%1.52M

2.71%379K

2.43%379K

2.71%379K

-Depreciation and amortization

432.45%2.02M

37.86%2.09M

151.45%953K

0.26%380K

-0.26%378K

0.00%379K

2.57%1.52M

2.71%379K

2.43%379K

2.71%379K

Operating profit

-560.83%-9.24M

-320.45%-13.95M

-207.01%-7.09M

-253.40%-6M

-182.84%-2.87M

126.13%2M

-84.99%6.33M

-23.24%6.63M

-63.88%3.91M

-72.02%3.46M

Net non-operating interest income expense

Other net income (expense)

29.71%4.57M

308.19%20.29M

82.07%5.43M

278.30%5.88M

1,559.27%5.46M

3,256.19%3.52M

2,397.99%4.97M

11,576.92%2.98M

1,701.03%1.55M

40.00%329K

Other non- operating income (expenses)

29.71%4.57M

308.19%20.29M

82.07%5.43M

278.30%5.88M

1,559.27%5.46M

3,256.19%3.52M

2,397.99%4.97M

11,576.92%2.98M

1,701.03%1.55M

40.00%329K

Income before tax

-184.37%-4.66M

-43.90%6.34M

-117.28%-1.66M

-102.20%-120K

-31.61%2.59M

173.08%5.53M

-73.33%11.3M

11.65%9.61M

-49.07%5.46M

-69.93%3.79M

Income tax

-122.76%-518K

-23.78%3.83M

-73.15%739K

-111.73%-257K

-11.84%1.07M

300.71%2.28M

-45.45%5.03M

79.63%2.75M

-25.75%2.19M

-58.79%1.22M

Net income

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

-57.92%3.27M

-73.33%2.57M

Net income continuous Operations

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

-57.92%3.27M

-73.33%2.57M

Minority interest income

Net income attributable to the parent company

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

-57.92%3.27M

-73.33%2.57M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-227.49%-4.15M

-60.02%2.51M

-134.98%-2.4M

-95.81%137K

-40.95%1.52M

150.58%3.25M

-81.07%6.28M

-3.07%6.86M

-57.92%3.27M

-73.33%2.57M

Basic earnings per share

-216.67%-0.07

-63.64%0.04

-133.33%-0.04

-96.03%0.0024

-40.00%0.03

154.55%0.06

-81.67%0.11

-7.69%0.12

-57.14%0.06

-70.59%0.05

Diluted earnings per share

-216.67%-0.07

-63.64%0.04

-133.33%-0.04

-96.04%0.0024

-40.00%0.03

154.55%0.06

-81.03%0.11

0.00%0.12

-57.14%0.06

-70.59%0.05

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	-24.06%47.46M	-24.27%192.64M	-29.79%45.27M	-40.58%38.82M	-28.47%46.06M	3.83%62.5M	-5.32%254.38M	-5.20%64.48M	-6.82%65.32M	-5.17%64.39M
Operating revenue	-24.06%47.46M	-24.27%192.64M	-29.79%45.27M	-40.58%38.82M	-28.47%46.06M	3.83%62.5M	-5.32%254.38M	-5.20%64.48M	-6.82%65.32M	-5.17%64.39M
Cost of revenue	-27.94%3.44M	-39.07%14.8M	-44.53%3.46M	-51.53%3.06M	-42.25%3.5M	-15.73%4.77M	-5.26%24.28M	0.03%6.24M	-7.02%6.32M	-7.72%6.06M
Gross profit	-23.74%44.02M	-22.71%177.84M	-28.21%41.81M	-39.40%35.75M	-27.04%42.56M	5.86%57.72M	-5.33%230.1M	-5.73%58.24M	-6.79%59M	-4.89%58.33M
Operating expense	-4.42%53.26M	-14.29%191.8M	-5.25%48.91M	-24.22%41.75M	-17.22%45.42M	-10.41%55.72M	11.39%223.77M	-2.88%51.62M	4.98%55.09M	12.06%54.87M
Selling and administrative expenses	-16.67%30.09M	-17.29%112.88M	-27.97%23.61M	-17.04%24.77M	-13.95%28.4M	-11.61%36.1M	10.03%136.49M	-1.99%32.78M	-8.02%29.85M	16.42%33M
Research and development costs	9.97%21.15M	-10.43%76.82M	31.89%24.34M	-33.22%16.6M	-22.54%16.65M	-8.26%19.24M	13.81%85.77M	-4.54%18.45M	26.48%24.86M	6.13%21.49M
Depreciation amortization depletion	432.45%2.02M	37.86%2.09M	151.45%953K	0.26%380K	-0.26%378K	0.00%379K	2.57%1.52M	2.71%379K	2.43%379K	2.71%379K
-Depreciation and amortization	432.45%2.02M	37.86%2.09M	151.45%953K	0.26%380K	-0.26%378K	0.00%379K	2.57%1.52M	2.71%379K	2.43%379K	2.71%379K
Operating profit	-560.83%-9.24M	-320.45%-13.95M	-207.01%-7.09M	-253.40%-6M	-182.84%-2.87M	126.13%2M	-84.99%6.33M	-23.24%6.63M	-63.88%3.91M	-72.02%3.46M
Net non-operating interest income expense
Other net income (expense)	29.71%4.57M	308.19%20.29M	82.07%5.43M	278.30%5.88M	1,559.27%5.46M	3,256.19%3.52M	2,397.99%4.97M	11,576.92%2.98M	1,701.03%1.55M	40.00%329K
Other non- operating income (expenses)	29.71%4.57M	308.19%20.29M	82.07%5.43M	278.30%5.88M	1,559.27%5.46M	3,256.19%3.52M	2,397.99%4.97M	11,576.92%2.98M	1,701.03%1.55M	40.00%329K
Income before tax	-184.37%-4.66M	-43.90%6.34M	-117.28%-1.66M	-102.20%-120K	-31.61%2.59M	173.08%5.53M	-73.33%11.3M	11.65%9.61M	-49.07%5.46M	-69.93%3.79M
Income tax	-122.76%-518K	-23.78%3.83M	-73.15%739K	-111.73%-257K	-11.84%1.07M	300.71%2.28M	-45.45%5.03M	79.63%2.75M	-25.75%2.19M	-58.79%1.22M
Net income	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M	-57.92%3.27M	-73.33%2.57M
Net income continuous Operations	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M	-57.92%3.27M	-73.33%2.57M
Minority interest income
Net income attributable to the parent company	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M	-57.92%3.27M	-73.33%2.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-227.49%-4.15M	-60.02%2.51M	-134.98%-2.4M	-95.81%137K	-40.95%1.52M	150.58%3.25M	-81.07%6.28M	-3.07%6.86M	-57.92%3.27M	-73.33%2.57M
Basic earnings per share	-216.67%-0.07	-63.64%0.04	-133.33%-0.04	-96.03%0.0024	-40.00%0.03	154.55%0.06	-81.67%0.11	-7.69%0.12	-57.14%0.06	-70.59%0.05
Diluted earnings per share	-216.67%-0.07	-63.64%0.04	-133.33%-0.04	-96.04%0.0024	-40.00%0.03	154.55%0.06	-81.03%0.11	0.00%0.12	-57.14%0.06	-70.59%0.05
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall